Zions Bancorporation’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $6.69M | Buy |
12,862
+1,407
| +12% | +$774K | 0.42% | 42 |
|
|
2024
Q3 | $7.09M | Buy |
11,455
+907
| +9% | +$537K | 0.52% | 28 |
|
|
2024
Q2 | $5.83M | Sell |
10,548
-620
| -6% | -$355K | 0.47% | 38 |
|
|
2024
Q1 | $6.49M | Sell |
11,168
-41
| -0.4% | -$23K | 0.48% | 31 |
|
|
2023
Q4 | $5.95M | Buy |
11,209
+2,480
| +28% | +$1.2M | 0.41% | 37 |
|
|
2023
Q3 | $4.42M | Buy |
8,729
+1,464
| +20% | +$780K | 0.39% | 43 |
|
|
2023
Q2 | $3.79M | Sell |
7,265
-1,453
| -17% | -$784K | 0.32% | 53 |
|
|
2023
Q1 | $5.02M | Sell |
8,718
-173
| -2% | -$97.5K | 0.43% | 36 |
|
|
2022
Q4 | $4.9M | Buy |
8,891
+662
| +8% | +$351K | 0.39% | 36 |
|
|
2022
Q3 | $4.17M | Buy |
8,229
+191
| +2% | +$107K | 0.44% | 32 |
|
|
2022
Q2 | $4.37M | Buy |
8,038
+953
| +13% | +$525K | 0.44% | 34 |
|
|
2022
Q1 | $4.18M | Buy |
7,085
+2,206
| +45% | +$1.27M | 0.38% | 37 |
|
|
2021
Q4 | $3.25M | Buy |
4,879
+408
| +9% | +$255K | 0.29% | 42 |
|
|
2021
Q3 | $2.55M | Buy |
4,471
+550
| +14% | +$302K | 0.26% | 45 |
|
|
2021
Q2 | $1.98M | Buy |
3,921
+426
| +12% | +$201K | 0.2% | 57 |
|
|
2021
Q1 | $1.59M | Buy |
3,495
+658
| +23% | +$314K | 0.18% | 61 |
|
|
2020
Q4 | $1.32M | Sell |
2,837
-894
| -24% | -$419K | 0.17% | 62 |
|
|
2020
Q3 | $1.65M | Sell |
3,731
-128
| -3% | -$52.9K | 0.23% | 49 |
|
|
2020
Q2 | $1.4M | Buy |
3,859
+293
| +8% | +$98.2K | 0.2% | 55 |
|
|
2020
Q1 | $1.01M | Buy |
3,566
+40
| +1% | +$12.6K | 0.18% | 57 |
|
|
2019
Q4 | $1.15M | Sell |
3,526
-118
| -3% | -$35.8K | 0.16% | 55 |
|
|
2019
Q3 | $1.06M | Buy |
3,644
+49
| +1% | +$14K | 0.15% | 59 |
|
|
2019
Q2 | $1.06M | Buy |
3,595
+5
| +0.1% | +$1.38K | 0.15% | 57 |
|
|
2019
Q1 | $983K | Buy |
+3,590
| New | +$893K | 0.16% | 66 |
|
|
2018
Q4 | – | Sell |
-3,750
| Closed | -$915K | – | 731 |
|
|
2018
Q3 | $915K | Buy |
+3,750
| New | +$863K | 0.22% | 57 |
|
|
2018
Q1 | – | Sell |
-3,135
| Closed | -$595K | – | 680 |
|
|
2017
Q4 | $595K | Sell |
3,135
-320
| -9% | -$61.3K | 0.1% | 82 |
|
|
2017
Q3 | $654K | Buy |
3,455
+3,376
| +4,273% | +$611K | 0.09% | 123 |
|
|
2017
Q2 | $14K | Sell |
79
-54
| -41% | -$9.07K | ﹤0.01% | 311 |
|
|
2017
Q1 | $19K | Sell |
133
-210
| -61% | -$32.1K | ﹤0.01% | 288 |
|
|
2016
Q4 | $48K | Sell |
343
-57
| -14% | -$8.4K | 0.01% | 246 |
|
|
2016
Q3 | $61K | Buy |
400
+112
| +39% | +$17.3K | 0.01% | 213 |
|
|
2016
Q2 | $44K | Sell |
288
-62
| -18% | -$9.15K | 0.01% | 224 |
|
|
2016
Q1 | $51K | Sell |
350
-1
| -0.3% | -$134 | 0.01% | 237 |
|
|
2015
Q4 | $43K | Buy |
351
+27
| +8% | +$3.6K | 0.01% | 226 |
|
|
2015
Q3 | $44K | Buy |
+324
| New | +$42.2K | 0.01% | 227 |
|
|
2015
Q2 | – | Sell |
-234
| Closed | -$31K | – | 694 |
|
|
2015
Q1 | $31K | Buy |
+234
| New | +$30.2K | 0.01% | 294 |
|
Other funds holding TMO
Zions Bancorporation's TMO Position: Q4 2024 in Review
Zions Bancorporation increased its Thermo Fisher Scientific (TMO) stake by 12% in Q4 2024, buying an estimated $774K and bringing the position to 12,862 shares worth $6.69M. The position accounts for 0.42% of the portfolio, ranked #42.
Zions Bancorporation first reported a position in TMO in Q1 2015 and has held it in 36 quarters since. The position peaked at $7.09M in Q3 2024. 2,617 funds tracked by Wall St. Rank hold TMO as of Q4 2024.
- Zions Bancorporation held 12,862 shares of Thermo Fisher Scientific worth $6.69M as of Q4 2024.
- Zions Bancorporation bought 1,407 Thermo Fisher Scientific shares in Q4 2024, an estimated $774K.
- Thermo Fisher Scientific made up 0.42% of Zions Bancorporation's portfolio in Q4 2024, its #42 holding.
- Zions Bancorporation first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 36 quarters since.
- Zions Bancorporation's Thermo Fisher Scientific position peaked at $7.09M in Q3 2024.
- 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.